News The latest in Phoreus & Med Technology

OLATHE, KS, September 9, 2021 – Phoreus Biotech, a leading provider of next-generation peptide nanocarriers, today announces that Steve Schram has been named Chief Executive Officer. Schram brings nearly 38 years of experience leading multiple…

OLATHE, KS, June 24, 2021 – Phoreus Biotechnology, a leading provider of next-generation peptide nanocarriers, has won the Animal Health Innovation USA Innovation Showcase at the virtual event which took place June 15-16, 2021. The…

All too often, researchers doing cell transfection must conduct a careful balancing act. Achieving a level of transfection that’s high enough to provide reliable results, without killing too many cells in the process, is a…

Oral delivery of nucleic acids for the purpose of cell transfection is an exciting new delivery method that could improve outcomes for DNA vaccination and gene therapy. It serves as a non-invasive application and makes…

Branched Amphipathic Peptide Capsules (BAPC) are nanospheres made from an equimolar mixture of two branched peptides:  bis(Ac-FLIVIGSII)-K-K4-CO-NH2 and bis(Ac-FLIVI)-K-K4-CO-NH2. These peptides self-assemble to form solvent-filled, bilayer defined capsules and originate from one of the pore-forming…